Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?
- PMID: 32953711
- PMCID: PMC7475410
- DOI: 10.21037/atm-2020-34
Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-2020-34). The authors have no conflicts of interest to declare.
Comment on
-
Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.Ann Transl Med. 2019 Nov;7(22):660. doi: 10.21037/atm.2019.10.75. Ann Transl Med. 2019. PMID: 31930061 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources